IRIDEX (IRIX) CFO adds 1,000 shares in open-market purchase

Rhea-AI Filing Summary

IRIDEX Corp’s Chief Financial Officer, Romeo R. Dizon, reported an open-market purchase of common stock. On 02/10/2026, he acquired 1,000 shares of IRIDEX common stock at a price of $1.46 per share.

Following this transaction, Dizon directly beneficially owned a total of 116,190 shares of IRIDEX common stock. The filing indicates the ownership is held directly, and the Form 4 was signed on his behalf by attorney-in-fact Nilo De Castro.

Insider Trade Summary

Net Buyer: 1,000 shares ($1,460)

Net Buy 1 txn

Insider Dizon Romeo R

Role Chief Financial Officer

Bought 1,000 shs ($1K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	1,000	$1.46	$1K

Holdings After Transaction: Common Stock — 116,190 shares (Direct)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dizon Romeo R

(Last) (First) (Middle)

1212 TERRA BELLA AVENUE

(Street)

MOUNTAIN VIEW CA 94043

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IRIDEX CORP [ IRIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/10/2026		P		1,000	A	$1.46	116,190	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Nilo De Castro, Attorney-in-fact for Romeo R. Dizon	02/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did IRIDEX (IRIX) report for its CFO?

IRIDEX reported that its Chief Financial Officer, Romeo R. Dizon, bought 1,000 shares of common stock. The purchase occurred on 02/10/2026 at a price of $1.46 per share, as disclosed in a Form 4 insider trading report.

How many IRIDEX (IRIX) shares does the CFO own after this Form 4 transaction?

After the reported transaction, CFO Romeo R. Dizon beneficially owned 116,190 shares of IRIDEX common stock. This total reflects his direct holdings following the 1,000-share purchase on 02/10/2026 at a per-share price of $1.46.

Was the IRIDEX (IRIX) CFO’s February 2026 trade a purchase or a sale?

The trade reported for IRIDEX’s CFO was a purchase of common stock, coded as “P” on Form 4. He acquired 1,000 shares on 02/10/2026 at a price of $1.46 per share in a non-derivative transaction.

What price did the IRIDEX (IRIX) CFO pay per share in the latest Form 4 filing?

CFO Romeo R. Dizon paid $1.46 per share for IRIDEX common stock in the reported transaction. The Form 4 shows this price for the 1,000 shares of common stock purchased on 02/10/2026 in an open-market acquisition.

Is the IRIDEX (IRIX) CFO’s ownership reported as direct or indirect in this Form 4?

The CFO’s holdings are reported as directly owned in the Form 4 filing. Following the 1,000-share purchase on 02/10/2026 at $1.46 per share, Romeo R. Dizon is shown as directly beneficially owning 116,190 IRIDEX common shares.

Who signed the IRIDEX (IRIX) Form 4 reporting the CFO’s share purchase?

The Form 4 was signed by Nilo De Castro as attorney-in-fact for Romeo R. Dizon. This indicates De Castro was authorized to execute the insider trading report that disclosed the CFO’s 1,000-share purchase of IRIDEX common stock.